The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
Multiple Drug Resistance Mechanisms in Cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
A JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
(1909) · Journal of the American Medical Association · doi:10.1001/jama.1909.02550020033007 · Cited by 7,866
Massagué, J. (2008) · Cell · doi:10.1016/j.cell.2008.07.001 · Cited by 3,907
Targeting multidrug resistance in cancer
Szakács, G., Paterson, J. K., Ludwig, J. A., Booth-Genthe, C., & Gottesman, M. M. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1984 · Cited by 3,609 · cited 1×
“The first is to co-administer a drug that inhibits the action of the transporter [3] while the second is to design or utilise anticancer drugs whose activity is not significantly altered by the presence of transporters [7].”
BackgroundOncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network
Kuilman, T., Michaloglou, C., Vredeveld, L. C. W., Douma, S., van Doorn, R., Desmet, C. J., Aarden, L. A., Mooi, W. J., & Peeper, D. S. (2008) · Cell · doi:10.1016/j.cell.2008.03.039 · Cited by 2,086 · cited 1×
“These mechanisms may induce senescence rather than quiescence; for instance, acquisition of genetic changes has the effect of inducing cellular stress responses involving the secretion of specific proteins, such as the interleukins IL-6 and IL-8, which induce senescence of tumour cells [62, 63].”
BackgroundWnt activity defines colon cancer stem cells and is regulated by the microenvironment
Vermeulen, L., De Sousa E Melo, F., van der Heijden, M., Cameron, K., de Jong, J. H., Borovski, T., Tuynman, J. B., Todaro, M., Merz, C., Rodermond, H., et al. (2010) · Nature Cell Biology · doi:10.1038/ncb2048 · Cited by 1,804
Immunological aspects of cancer chemotherapy
Zitvogel, L., Apetoh, L., Ghiringhelli, F., & Kroemer, G. (2008) · Nature Reviews Immunology · doi:10.1038/nri2216 · Cited by 1,712
Models, mechanisms and clinical evidence for cancer dormancy
Aguirre-Ghiso, J. A. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2256 · Cited by 1,677
Tumor Response to Radiotherapy Regulated by Endothelial Cell Apoptosis
Garcia-Barros, M., Paris, F., Cordon-Cardo, C., Lyden, D., Rafii, S., Haimovitz-Friedman, A., Fuks, Z., & Kolesnick, R. (2003) · Science · doi:10.1126/science.1082504 · Cited by 1,593
Adaptive immunity maintains occult cancer in an equilibrium state
Koebel, C. M., Vermi, W., Swann, J. B., Zerafa, N., Rodig, S. J., Old, L. J., Smyth, M. J., & Schreiber, R. D. (2007) · Nature · doi:10.1038/nature06309 · Cited by 1,436
SISSAOUI, M. (2018) · Archives of Clinical Microbiology · doi:10.4172/1989-8436-c3-011 · Cited by 1,349
Coexistence of Quiescent and Active Adult Stem Cells in Mammals
Li, L., & Clevers, H. (2010) · Science · doi:10.1126/science.1180794 · Cited by 1,247 · cited 1×
“It is becoming apparent that the proliferation status of stem cells in normal tissue depends on their location [48].”
BackgroundRoesch, A., Fukunaga-Kalabis, M., Schmidt, E. C., Zabierowski, S. E., Brafford, P. A., Vultur, A., Basu, D., Gimotty, P., Vogt, T., & Herlyn, M. (2010) · Cell · doi:10.1016/j.cell.2010.04.020 · Cited by 1,158
Suzuki, E., Kapoor, V., Jassar, A. S., Kaiser, L. R., & Albelda, S. M. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0883 · Cited by 1,054
Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxia
Parmar, K., Mauch, P., Vergilio, J.-A., Sackstein, R., & Down, J. D. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701152104 · Cited by 867
Pharmacological Rescue of Mutant p53 Conformation and Function
Foster, B. A., Coffey, H. A., Morin, M. J., & Rastinejad, F. (1999) · Science · doi:10.1126/science.286.5449.2507 · Cited by 799
Serra, V., Markman, B., Scaltriti, M., Eichhorn, P. J. A., Valero, V., Guzman, M., Botero, M. L., Llonch, E., Atzori, F., Di Cosimo, S., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1385 · Cited by 787
A fresh look at tumor immunosurveillance and immunotherapy
Smyth, M. J., Godfrey, D. I., & Trapani, J. A. (2001) · Nature Immunology · doi:10.1038/86297 · Cited by 745
Nuclear factor-κB inhibitors as sensitizers to anticancer drugs
Nakanishi, C., & Toi, M. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1588 · Cited by 724
Nguyen, M., Marcellus, R. C., Roulston, A., Watson, M., Serfass, L., Murthy Madiraju, S. R., Goulet, D., Viallet, J., Bélec, L., Billot, X., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709443104 · Cited by 659
Multidrug resistance: molecular mechanisms and clinical relevance
Ling, V. (1997) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800051053 · Cited by 522
The Bone Marrow Microenvironment as a Tumor Sanctuary and Contributor to Drug Resistance
Meads, M. B., Hazlehurst, L. A., & Dalton, W. S. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-2223 · Cited by 520
Sotiriou, C., & Piccart, M. J. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2173 · Cited by 461
BCL-2 Family Proteins: Critical Checkpoints of Apoptotic Cell Death
Danial, N. N. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1598 · Cited by 433
Mechanisms and strategies to overcome multiple drug resistance in cancer
Ozben, T. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.02.020 · Cited by 406
Phosphoinositide signalling in cancer: beyond PI3K and PTEN
Bunney, T. D., & Katan, M. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2842 · Cited by 400 · cited 1×
“The development of inhibitors of PI3K, which induce apoptosis by reducing phosphorylation of AKT and thus of phosphorylation of one (bad) of the bcl2 family members is now a major aim of the pharmaceutical industry [44, 45].”
BackgroundThe co-translocation of ERp57 and calreticulin determines the immunogenicity of cell death
Panaretakis, T., Joza, N., Modjtahedi, N., Tesniere, A., Vitale, I., Durchschlag, M., Fimia, G. M., Kepp, O., Piacentini, M., Froehlich, K.-U., et al. (2008) · Cell Death & Differentiation · doi:10.1038/cdd.2008.67 · Cited by 344
Chemotherapy-induced resistance by ATP-binding cassette transporter genes
GILLET, J., EFFERTH, T., & REMACLE, J. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2007.05.002 · Cited by 337
p38 MAP kinase: a convergence point in cancer therapy
Olson, J. M., & Hallahan, A. R. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.01.007 · Cited by 335
SP analysis may be used to identify cancer stem cell populations
Hadnagy, A., Gaboury, L., Beaulieu, R., & Balicki, D. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2006.08.030 · Cited by 306
Müller-Hermelink, N., Braumüller, H., Pichler, B., Wieder, T., Mailhammer, R., Schaak, K., Ghoreschi, K., Yazdi, A., Haubner, R., Sander, C. A., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.04.001 · Cited by 302
Fatal Melanoma Transferred in a Donated Kidney 16 Years after Melanoma Surgery
MacKie, R. M., Reid, R., & Junor, B. (2003) · New England Journal of Medicine · doi:10.1056/nejm200302063480620 · Cited by 290
ABCG2 – a transporter for all seasons
Sarkadi, B., Özvegy-Laczka, C., Német, K., & Váradi, A. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.03.123 · Cited by 282
Dubikovskaya, E. A., Thorne, S. H., Pillow, T. H., Contag, C. H., & Wender, P. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805374105 · Cited by 249
A common signaling cascade may underlie “addiction” to the Src, BCR-ABL, and EGF receptor oncogenes
Sharma, S. V., Gajowniczek, P., Way, I. P., Lee, D. Y., Jiang, J., Yuza, Y., Classon, M., Haber, D. A., & Settleman, J. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.09.014 · Cited by 233
Wang, W., McLeod, H. L., & Cassidy, J. (2003) · International Journal of Cancer · doi:10.1002/ijc.10972 · Cited by 226
Cancers Exhibit a Mutator Phenotype: Clinical Implications
Loeb, L. A., Bielas, J. H., & Beckman, R. A. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5835 · Cited by 221
Epigenetic targets in hematopoietic malignancies
Claus, R., & Lübbert, M. (2003) · Oncogene · doi:10.1038/sj.onc.1206814 · Cited by 214
Tumor dormancy and surgery-driven interruption of dormancy in breast cancer: learning from failures
Demicheli, R., Retsky, M. W., Hrushesky, W. J., & Baum, M. (2007) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0999 · Cited by 205
Cancers take their Toll—the function and regulation of Toll-like receptors in cancer cells
Chen, R., Alvero, A. B., Silasi, D.-A., Steffensen, K. D., & Mor, G. (2008) · Oncogene · doi:10.1038/sj.onc.1210907 · Cited by 199
Mechanisms of multidrug transporters
Bolhuis, H. (1997) · FEMS Microbiology Reviews · doi:10.1016/s0168-6445(97)00051-x · Cited by 188
Chen, K. G., Valencia, J. C., Lai, B., Zhang, G., Paterson, J. K., Rouzaud, F., Berens, W., Wincovitch, S. M., Garfield, S. H., Leapman, R. D., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600213103 · Cited by 186
The Role of ATP Binding Cassette Transporters in Tissue Defense and Organ Regeneration
Huls, M., Russel, F. G. M., & Masereeuw, R. (2009) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.132225 · Cited by 183
Transferable anticancer innate immunity in spontaneous regression/complete resistance mice
Hicks, A. M., Riedlinger, G., Willingham, M. C., Alexander-Miller, M. A., Von Kap-Herr, C., Pettenati, M. J., Sanders, A. M., Weir, H. M., Du, W., Kim, J., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602382103 · Cited by 165
Upregulation of Twist-1 by NF-κB Blocks Cytotoxicity Induced by Chemotherapeutic Drugs
Pham, C. G., Bubici, C., Zazzeroni, F., Knabb, J. R., Papa, S., Kuntzen, C., & Franzoso, G. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01219-06 · Cited by 162
Multidrug Resistance and Cancer: The Role of the Human ABC Transporter ABCG2
Ejendal, K. F., & Hrycyna, C. A. (2002) · Current Protein & Peptide Science · doi:10.2174/1389203023380521 · Cited by 161
Multidrug Resistance in Cancer
Baguley, B. C. (2009) · Methods in molecular biology · doi:10.1007/978-1-60761-416-6_1 · Cited by 160
Self-citationChemotherapy Sensitivity and Resistance Assays: A Systematic Review
Samson, D. J., Seidenfeld, J., Ziegler, K. M., & Aronson, N. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.04.077 · Cited by 138
p16INK4a Prevents Centrosome Dysfunction and Genomic Instability in Primary Cells
McDermott, K. M., Zhang, J., Holst, C. R., Kozakiewicz, B. K., Singla, V., & Tlsty, T. D. (2006) · PLoS Biology · doi:10.1371/journal.pbio.0040051 · Cited by 137
MDR1 expression identifies human melanoma stem cells
Keshet, G. I., Goldstein, I., Itzhaki, O., Cesarkas, K., Shenhav, L., Yakirevitch, A., Treves, A. J., Schachter, J., Amariglio, N., & Rechavi, G. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.02.022 · Cited by 124
MEK Inhibitors: A Therapeutic Approach to Targeting the Ras-MAP Kinase Pathway in Tumors
Sebolt–Leopold, J. S. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043384439 · Cited by 123
(1973) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(73)90155-4 · Cited by 122
A Phase I Study of the P-Glycoprotein Antagonist Tariquidar in Combination with Vinorelbine
Abraham, J., Edgerly, M., Wilson, R. H., Chen, C. C., Rutt, A., Bakke, S., Robey, R. W., Dwyer, A., Goldspiel, B. R., Balis, F. M., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0938 · Cited by 119
Loebinger, M. R., Giangreco, A., Groot, K. R., Prichard, L. B., Allen, K., Simpson, C. D., Bazley, L., Navani, N., Tibrewal, S., Davies, D. C., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604185 · Cited by 117
Control of senescence by CXCR2 and its ligands
Acosta, J. C., Loghlen, A., Banito, A., Raguz, S., & Gil, J. (2008) · Cell Cycle · doi:10.4161/cc.7.19.6780 · Cited by 106 · cited 1×
“These mechanisms may induce senescence rather than quiescence; for instance, acquisition of genetic changes has the effect of inducing cellular stress responses involving the secretion of specific proteins, such as the interleukins IL-6 and IL-8, which induce senescence of tumour cells [62, 63].”
BackgroundBosserhoff, A., Kortylewski, M., Komyod, W., Kauffmann, M.-E., Heinrich, P. C., & Behrmann, I. (2004) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2004.22237.x · Cited by 103
Turco, M. C., Romano, M. F., Petrella, A., Bisogni, R., Tassone, P., & Venuta, S. (2003) · Leukemia · doi:10.1038/sj.leu.2403171 · Cited by 101
Krämer, A., Lukas, J., & Bártek, J. (2004) · Cell Cycle · doi:10.4161/cc.3.11.1252 · Cited by 90
Gandhi, L., Harding, M. W., Neubauer, M., Langer, C. J., Moore, M., Ross, H. J., Johnson, B. E., & Lynch, T. J. (2007) · Cancer · doi:10.1002/cncr.22492 · Cited by 90
Role of the ceramide-signaling pathways in ionizing radiation-induced apoptosis
Vit, J., & Rosselli, F. (2003) · Oncogene · doi:10.1038/sj.onc.1207087 · Cited by 88
Ruff, P., Vorobiof, D., Jordaan, J. P., Demetriou, G. S., Moodley, S. D., Nosworthy, A. L., Werner, I. D., Raats, J., & Burgess, L. J. (2009) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-009-0925-9 · Cited by 85
Capitalizing on the Immunogenicity of Dying Tumor Cells
Fonseca, C., & Dranoff, G. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-2245 · Cited by 63
Potential for therapeutic targeting of tumor stem cells
Saini, V., & Shoemaker, R. H. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01371.x · Cited by 62
Development of Phosphoinositide-3 Kinase Pathway Inhibitors for Advanced Cancer
Cleary, J. M., & Shapiro, G. I. (2010) · Current Oncology Reports · doi:10.1007/s11912-010-0091-6 · Cited by 62
Inoue, Y. (1994) · Oncology Reports · doi:10.3892/or_00000002 · Cited by 54
Current Strategies in Overcoming Resistance of Cancer Cells to Apoptosis Melanoma as a Model
Hersey, P., Zhuang, L., & Zhang, X. D. (2006) · International review of cytology · doi:10.1016/s0074-7696(06)51004-6 · Cited by 52
Analysis of Gene Expression in the Tumor-Associated Macrophage
Duff, M. D., MESTRE, J. R., Maddali, S., Yan, Z., Stapleton, P. P., & Daly, J. M. (2007) · Journal of Surgical Research · doi:10.1016/j.jss.2006.12.542 · Cited by 48
Forte, M. A., & Bernardi, P. (2006) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401957 · Cited by 45
Current Strategies to Target the Anti-Apoptotic Bcl-2 Protein in Cancer Cells
Oxford, S., Dallman, C., Johnson, P., Ganesan, A., & Packham, G. (2004) · Current Medicinal Chemistry · doi:10.2174/0929867043455486 · Cited by 42
Hicks, K. O., Pruijn, F. B., Baguley, B. C., & Wilson, W. R. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29637-3 · Cited by 42
Self-citationTumor Stem Cell Niches: A New Functional Framework for the Action of Anticancer Drugs
Baguley, B. C. (2006) · Recent Patents on Anti-Cancer Drug Discovery · doi:10.2174/157489206775246494 · Cited by 40
Self-citationIn vitro modelling of human tumour behaviour in drug discovery programmes
Baguley, B. C., & Marshall, E. S. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2003.12.019 · Cited by 38
Self-citationNovel Strategies for Overcoming Multidrug Resistance in Cancer
Baguley, B. C. (2002) · BioDrugs · doi:10.2165/00063030-200216020-00003 · Cited by 19
Self-citationThe use of human tumour cell lines in the discovery of new cancer chemotherapeutic drugs
Baguley, B. C., & Marshall, E. S. (2008) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.3.2.153 · Cited by 11
Self-citation
Cited by
Broad targeting of resistance to apoptosis in cancer
Mohammad, R. M., Muqbil, I., Lowe, L., Yedjou, C., Hsu, H.-Y., Lin, L.-T., Siegelin, M. D., Fimognari, C., Kumar, N. B., Dou, Q. P., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.03.001 · Cited by 864
Chen, Z., Shi, T., Zhang, L., Zhu, P., Deng, M., Huang, C., Hu, T., Jiang, L., & Li, J. (2016) · Cancer Letters · doi:10.1016/j.canlet.2015.10.010 · Cited by 729
The role and mechanisms of action of microRNAs in cancer drug resistance
Si, W., Shen, J., Zheng, H., & Fan, W. (2019) · Clinical Epigenetics · doi:10.1186/s13148-018-0587-8 · Cited by 668
miRNA-based biomarkers, therapies, and resistance in Cancer
He, B., Zhao, Z., Cai, Q., Zhang, Y., Zhang, P., Shi, S., Xie, H., Peng, X., Yin, W., Tao, Y., et al. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.47203 · Cited by 625
Multifunctional nanoparticle-mediated combining therapy for human diseases
Li, X., Peng, X., Zoulikha, M., Boafo, G. F., Magar, K. T., Ju, Y., & He, W. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01668-1 · Cited by 521
Metadata
- Authors
- Baguley, B. C.
- Venue
- Molecular Biotechnology
- Published
- 2010-08-18
- Volume
- 46
- Issue
- 3
- Pages
- 308-316
- ISSN
- 1073-6085 (ISSN-L)
- 1559-0305
- OpenAlex
- W1999729424
- Cited by
- 478
- References
- 74
- FWCI
- 13.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.